OTTO DAWN PARSELL (Sr VP, Clinical Development) sold 94.3% of their position (4.25K shares) of TRICIDA, INC. on the open market
Open‑market sale worth $156.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+210.00
Price / share
$1.68
Trade value
$352.80
% of position
Common Stock
Shares
−210.00
Price / share
$35.58
Trade value
$7.47K
% of position
Common Stock
Shares
+2.99K
Price / share
$1.68
Trade value
$5.03K
% of position
Common Stock
Shares
−258.00
Price / share
$35.58
Trade value
$9.18K
% of position
Common Stock
Shares
−2.34K
Price / share
$36.74
Trade value
$85.82K
% of position
Common Stock
Shares
−400.00
Price / share
$37.51
Trade value
$15K
% of position
Common Stock
Shares
+523.00
Price / share
$2.39
Trade value
$1.25K
% of position
Common Stock
Shares
−523.00
Price / share
$37.31
Trade value
$19.51K
% of position
Common Stock
Shares
+523.00
Price / share
$7.49
Trade value
$3.92K
% of position
Common Stock
Shares
−523.00
Price / share
$37.62
Trade value
$19.68K
% of position
Net shares
+0.00
Net value
-$146.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2020 | M · Option Exercise | +210.00 | $1.68 | $352.80 | 82.4% | 255.00 | 465.00 |
| Common Stock Direct | 2/3/2020 | S · Sale | −210.00 | $35.58 | $7.47K | 45.2% | 465.00 | 255.00 |
| Common Stock Direct | 2/3/2020 | M · Option Exercise | +2.99K | $1.68 | $5.03K | 1174.1% | 255.00 | 3.25K |
| Common Stock Direct | 2/3/2020 | S · Sale | −258.00 | $35.58 | $9.18K | 7.9% | 3.25K | 2.99K |
| Common Stock Direct | 2/3/2020 | S · Sale | −2.34K | $36.74 | $85.82K | 78.1% | 2.99K | 655.00 |
| Common Stock Direct | 2/3/2020 | S · Sale | −400.00 | $37.51 | $15K | 61.1% | 655.00 | 255.00 |
| Common Stock Direct | 2/3/2020 | M · Option Exercise | +523.00 | $2.39 | $1.25K | 205.1% | 255.00 | 778.00 |
| Common Stock Direct | 2/3/2020 | S · Sale | −523.00 | $37.31 | $19.51K | 67.2% | 778.00 | 255.00 |
| Common Stock Direct | 2/3/2020 | M · Option Exercise | +523.00 | $7.49 | $3.92K | 205.1% | 255.00 | 778.00 |
| Common Stock Direct | 2/3/2020 | S · Sale | −523.00 | $37.62 | $19.68K | 67.2% | 778.00 | 255.00 |
| Total | +0.00 | -$146.12K | ||||||
Employee Stock Option (right to buy)
Common Stock
210.00 shares
Shares
−210.00
Strike price
1.68
Held after
1.05K
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
2.99K shares
Shares
−2.99K
Strike price
1.68
Held after
11.81K
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
523.00 shares
Shares
−523.00
Strike price
2.39
Held after
18.32K
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
523.00 shares
Shares
−523.00
Strike price
7.49
Held after
24.60K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock210.00 shares | 2/3/2020 | M · Option Exercise | −210.00 | 1.68 | — | 1.05K |
| Employee Stock Option (right to buy) Direct | Common Stock2.99K shares | 2/3/2020 | M · Option Exercise | −2.99K | 1.68 | — | 11.81K |
| Employee Stock Option (right to buy) Direct | Common Stock523.00 shares | 2/3/2020 | M · Option Exercise | −523.00 | 2.39 | — | 18.32K |
| Employee Stock Option (right to buy) Direct | Common Stock523.00 shares | 2/3/2020 | M · Option Exercise | −523.00 | 7.49 | — | 24.60K |